BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32744683)

  • 1. MiR-20a regulates fibroblast-like synoviocyte proliferation and apoptosis in rheumatoid arthritis.
    Wei XJ; Li XW; Lu JL; Long ZX; Liang JQ; Wei SB; Lu CX; Lu WZ
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7578. PubMed ID: 32744683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
    Li XD; Li XM; Gu JW; Sun XC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7577. PubMed ID: 32744682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
    Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7575. PubMed ID: 32744680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2.
    Wei H; He WR; Chen KM; Wang XW; Yi CJ
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3147. PubMed ID: 33928594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
    Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7202. PubMed ID: 32706040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
    Li HL; Liang S; Cui JH; Han GY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7574. PubMed ID: 32744679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
    Wei RJ; Zhang CH; Yang WZ
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8239. PubMed ID: 32894521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7550. PubMed ID: 32744655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.
    Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7914. PubMed ID: 32767307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1.
    Song B; Tang YJ; Zhang WG; Wan CC; Chen Y; Zhang LJ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9237. PubMed ID: 33015758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5.
    Wang DZ; Jing SF; Hao SB; Huang XY; Miao QT; Gao JF
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8242. PubMed ID: 32894525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Dong ZC; Zhang D; Wang SB; Lin ZQ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10301. PubMed ID: 33155265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.
    Zhang JY; Li YN; Mu X; Pan ZL; Liu WB
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7911. PubMed ID: 32767305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
    Han GY; Cui JH; Liang S; Li HL
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11464. PubMed ID: 33275204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3β/β-catenin pathway.
    Dong ZC; Zhang D; Zhang XX; Yao ZQ; Wu H; Chen CH; Tian JQ
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11990. PubMed ID: 33336717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG16 functions as an oncogene by sponging miR-200a-3p in pancreatic cancer.
    Guo JQ; Yang ZJ; Wang S; Wu ZZ; Yin LL; Wang DC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7218. PubMed ID: 32706056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.
    Cao HY; Xiao CH; Lu HJ; Yu HZ; Hong H; Guo CY; Yuan JF
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11468. PubMed ID: 33275208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3.
    Wang J; Guo J; Fan H
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12625. PubMed ID: 33378006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
    Yu X; Wang ZL; Han CL; Wang MW; Jin Y; Jin XB; Xia QH
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7203. PubMed ID: 32706041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
    Liu CJ; Yang JH; Huang FZ; Yang JH; Liu CP; Mao XH; Yi WM; Shen XB; Peng C; Chen MF; Jiang B; Wu JS
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7909. PubMed ID: 32767303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.